Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.66147 | 27 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.60778 | 26 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.61418 | 27 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.47909 | 23 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.549 | 26 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.73812 | 29 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.80435 | 33 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.58485 | 26 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.56883 | 26 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.59431 | 26 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.59449 | 26 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.54965 | 25 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.60112 | 26 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.60137 | 26 |